Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[Severe pseudouveitis associated with moxifloxacin therapy].

Duncombe A, Gueudry J, Massy N, Chapuzet C, Gueit I, Muraine M.

J Fr Ophtalmol. 2013 Feb;36(2):146-50. doi: 10.1016/j.jfo.2012.07.002. Epub 2012 Nov 27. French.

2.

Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, De Waard PW, Missotten TO, Martinez Ciriano JP, Van Aken E.

Eye (Lond). 2009 Dec;23(12):2260-2. doi: 10.1038/eye.2009.234.

PMID:
19851342
3.

Bilateral uveitis associated with fluoroquinolone therapy.

Hinkle DM, Dacey MS, Mandelcorn E, Kalyani P, Mauro J, Bates JH, Soukasian SH, Holland GN, Foster CS, Fraunfelder FT, Davis JL, Fraunfelder FW.

Cutan Ocul Toxicol. 2012 Jun;31(2):111-6. doi: 10.3109/15569527.2011.617024. Epub 2011 Oct 8.

PMID:
21981449
4.

Clinical experience with moxifloxacin in patients with respiratory tract infections.

Faich GA, Morganroth J, Whitehouse AB, Brar JS, Arcuri P, Kowalsky SF, Haverstock DC, Celesk RA, Church DA.

Ann Pharmacother. 2004 May;38(5):749-54. Epub 2004 Mar 16.

PMID:
15026565
5.

Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.

Morshedi RG, Bettis DI, Moshirfar M, Vitale AT.

Ocul Immunol Inflamm. 2012 Aug;20(4):266-72. doi: 10.3109/09273948.2012.670359. Epub 2012 Jun 13. Review.

PMID:
22694259
6.

Moxifloxacin--a new fluoroquinolone antibacterial.

[No authors listed]

Drug Ther Bull. 2004 Aug;42(8):61-2. Review.

PMID:
15310155
7.

Moxifloxacin: a respiratory fluoroquinolone.

Miravitlles M, Anzueto A.

Expert Opin Pharmacother. 2008 Jul;9(10):1755-72. doi: 10.1517/14656566.9.10.1755 . Review.

PMID:
18570608
8.

[Acute and bilateral uveitis secondary to moxifloxacin].

Bringas Calvo R, Iglesias Cortiñas D.

Arch Soc Esp Oftalmol. 2004 Jul;79(7):357-9. Spanish.

PMID:
15286907
9.

A pharmacoeconomic review of the management of respiratory tract infections with moxifloxacin.

Simoens S, Decramer M.

Expert Opin Pharmacother. 2008 Jul;9(10):1735-44. doi: 10.1517/14656566.9.10.1735 . Review.

PMID:
18570606
10.
11.

Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.

Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G.

Int J Antimicrob Agents. 2007 Jan;29(1):56-61.

PMID:
17189096
12.

Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.

Kovacic D, Fox M, Reichenberg J.

J Drugs Dermatol. 2008 Aug;7(8):794-5.

PMID:
18720700
13.

[Efficacy of moxifloxacin in the treatment of respiratory tract infections: the Croatian post-marketing study].

Kuzman I, Kincl-Brodnjak V, Ermakora S, Kovacević D, Kuzman T.

Lijec Vjesn. 2005 Mar-Apr;127(3-4):77-81. Croatian.

PMID:
16193858
14.

Moxifloxacin-associated neutropenia.

Berk V, Demiraslan H, Berk E, Karaca H, Inanc M, Bozkurt O, Ozkan M.

Scand J Infect Dis. 2013 May;45(5):415-6. doi: 10.3109/00365548.2012.738937. Epub 2012 Nov 15.

PMID:
23151058
15.

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.

Wilson R, Anzueto A, Miravitlles M, Arvis P, Alder J, Haverstock D, Trajanovic M, Sethi S.

Eur Respir J. 2012 Jul;40(1):17-27. doi: 10.1183/09031936.00090311. Epub 2011 Dec 1. Erratum in: Eur Respir J. 2012 Sep;40(3):800.

16.
17.

Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.

Yoon H, Kim N, Lee BH, Hwang TJ, Lee DH, Park YS, Nam RH, Jung HC, Song IS.

Helicobacter. 2009 Oct;14(5):77-85. doi: 10.1111/j.1523-5378.2009.00709.x.

PMID:
19751431
18.
19.

Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.

Willermain F, Deflorenne C, Bouffioux C, Janssens X, Koch P, Caspers L.

Eye (Lond). 2010 Aug;24(8):1419; author reply 1419-20. doi: 10.1038/eye.2010.19. Epub 2010 Apr 9. No abstract available.

PMID:
20379213
20.

Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.

Chang B, Knowles SR, Weber E.

Ann Pharmacother. 2010 Apr;44(4):740-5. doi: 10.1345/aph.1M579. Epub 2010 Mar 16.

PMID:
20233910

Supplemental Content

Support Center